Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 854, pseudogene (RNU6-854P) is a human pseudogene corresponding to a U6 small nuclear RNA gene[1][4]. U6 small nuclear RNA (snRNA) participates in pre-mRNA splicing as a core component of the spliceosome, but RNU6-854P does not encode a functional RNA and is generally believed not to be transcribed or functional as a mature snRNA[1][4]. Like other U6 snRNA pseudogenes, it likely originated from retrotransposition or gene duplication events and is considered non-coding and biologically inactive[1][4][3]. There are no known disease associations, biological functions, or drug interactions for this specific pseudogene. Pseudogenes such as RNU6-854P may occasionally play regulatory roles in gene expression through antisense or miRNA-decoy mechanisms, but no evidence specifically implicates RNU6-854P in such functions[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 854, pseudogene (RNU6-854P).